Logo

Fasteris Buys Second Illumina Genome Analyzer

Apr 25, 2008
NEW YORK (GenomeWeb News) – Swiss sequencing services provider Fasteris said yesterday that it has purchased a second Genome Analyzer from Illumina.
 
Fasteris said that it bought a Genome Analyzer II, the latest generation of the high-throughput DNA sequencer, which enables paired-end reads.
 
The Geneva-based firm purchased its first Genome Analyzer a year ago and said that it would upgrade that system with the new optics of the GA II and with a paired-ends module.
 

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.